ARTV compared with SION: revenue, margins and what each company keeps, and the suppliers and customers both name

ARTVArtiva Biotherapeutics, Inc.

Mkt capRevenueRevenue

SIONSionna Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ARTVArtiva Biotherapeutics, Inc.

SIONSionna Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ARTV2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±76.2%▼−30.68%×0.40

Q2 FY26±35.1%▼−2.68%×0.08

SION

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+4.80%—

May 12 '26±10.9%▼−10.90%×1.00

= impliedARTV realized, solidSION realized, hatchedOne scale, both sides: full bar = 77%× = |realized| ÷ impliedspan: ARTV 81d · SION 274dSource: market data

Q1 FY26

—

▼−7.17%

—

Nov 5 '25—▼−1.57%—

ARTVArtiva Biotherapeutics, Inc.

4.22▲+1.57%· post 4.19

Mkt cap$208.6MRevenue$251,000Q1 FY24

SIONSionna Therapeutics, Inc.

3.58▲+9.04%· post 3.58

ClosedNov 9 '26

Mkt cap$161.2MRevenue—

Compare

ClosedNov 9 '26

ARTVArtiva Biotherapeutics, Inc.

SIONSionna Therapeutics, Inc.

4.22▲+1.57%post 4.19

Price

3.58▲+9.04%post 3.58

$208.6M

Mkt cap

$161.2M

Q1 FY24$251,000

Revenue

—

ARTV4.22▲+1.57%vsSION3.58▲+9.04%ClosedNov 9 '26